Synairgen starts dosing inhaled COVID-19 drug in phase 3 trialUK biotech Synairgen is pushing ahead with a phase 3 trial of SNG001 in hospitalised COVID-19 patients, after Share XSynairgen starts dosing inhaled COVID-19 drug in phase 3 trialhttps://pharmaphorum.com/news/synairgen-starts-dosing-inhaled-covid-19-drug-in-phase-3-trial/
Hepatitis drug could be tested against COVID-19 in IndiaIndia’s Zydus Cadila wants to test a form of interferon, usually used against hepatitis B and C, as Share XHepatitis drug could be tested against COVID-19 in Indiahttps://pharmaphorum.com/news/hepatitis-drug-interferon-could-be-tested-against-covid-19-in-india/
